|
SATELLITE SYMPOSIUM OF THE RESPIRATORY ONCOLOGY
RECENT ADVANCES IN LUNG CANCER: NEW TREATMENT OPTIONS LEADING TO NEW HOPE
{{ getTitle(live) }}
{{ toDate(live.liveStartDate) }}
{{ toTime(live.liveStartDate) }} - {{ toTime(live.liveEndDate) }}
{{ getNotification(live) }}
SCIENTIFIC PROGRAM
Chairs:
Prof. Dr. Johan Vansteenkiste, UZ Leuven
Prof. Dr. Anne Sibille, CHU Liège
| 19h30 | Introduction |
| 19h40 | CNS disease in lung cancer: How active are targeted and immunotherapies ? |
| Dr. Lizza Hendriks (pre-recorded), Maastricht UMC+, Netherlands | |
| 20h00 | Panel discussion and Q&A on CNS disease in lung cancer: How active are targeted and immunotherapies ? |
| Prof. Dr. Johan Vansteenkiste, Prof. Dr. Lore Decoster & Prof. Dr. Anne Sibille | |
| 20h15 | Immunotherapy: Is it too early for early stage NSCLC ? |
| Prof. Dr. Lore Decoster, UZ Brussels | |
| 20h40 | ALK translocated NSCLC: Few patients, but therapies galore ! |
| Prof. Dr. Solange Peters (virtual), CHU Vaudois, Lausanne, Switzerland. | |
| 21h05 | Closing |
Panel
Prof. Dr. Johan Vansteenkiste
UZ Leuven, Belgium
Prof. Dr. Anne Sibille
CHU de Liège, Belgium
Dr. Lizza Hendriks
Maastricht UMC+, Netherlands
Prof. Dr. Lore Decoster
UZ Brussel, Belgium
Prof. Dr. Solange Peters
CHU Vaudois Suisse
SCIENTIFIC PROGRAM
Chairs:
Prof. Dr. Johan Vansteenkiste, UZ Leuven
Prof. Dr. Anne Sibille, CHU Liège
| 19h30 | Introduction |
| 19h40 | CNS disease in lung cancer: How active are targeted and immunotherapies ? |
| Dr. Lizza Hendriks (pre-recorded), Maastricht UMC+, Netherlands | |
| 20h00 | Panel discussion and Q&A on CNS disease in lung cancer: How active are targeted and immunotherapies ? |
| Prof. Dr. Johan Vansteenkiste, Prof. Dr. Lore Decoster & Prof. Dr. Anne Sibille | |
| 20h15 | Immunotherapy: Is it too early for early stage NSCLC ? |
| Prof. Dr. Lore Decoster, UZ Brussels | |
| 20h40 | ALK translocated NSCLC: Few patients, but therapies galore ! |
| Prof. Dr. Solange Peters (virtual), CHU Vaudois, Lausanne, Switzerland. | |
| 21h05 | Closing |